Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115-6084, USA.
Proteomics. 2010 May;10(9):1880-5. doi: 10.1002/pmic.200900723.
Recent improvements in proteomic technologies have collectively yielded data sets that far exceed the capabilities of typical low-throughput interpretation strategies. Unfortunately, tools designed to leverage the "peptide-centric" content of MS-based proteomics lag the current rate of data production. Here, we describe Pathway Palette (http://blaispathways.dfci.harvard.edu), a freely accessible internet application that enables researchers to easily transition from peptides to biological pathways, while simultaneously retaining the qualitative and quantitative aspects of the underlying MS data.
近年来,蛋白质组学技术的进步使得数据集的数量大大超过了典型的低通量解释策略的能力。不幸的是,用于利用基于 MS 的蛋白质组学的“肽中心”内容的工具落后于当前的数据产生速度。在这里,我们描述了Pathway Palette(http://blaispathways.dfci.harvard.edu),这是一个免费的互联网应用程序,使研究人员能够轻松地从肽过渡到生物途径,同时保留基础 MS 数据的定性和定量方面。